CELG-RI
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$0.12
+9.71%Leverage
- Debt / equity
- 1.91x
- Net debt / equity
- 1.51x
- Debt / assets
- 0.50x
- Debt / EBITDA
- 2.96x
- Net debt / EBITDA
- 2.33x
Liquidity & coverage
- Current ratio
- 1.59x
- Quick ratio
- 1.44x
- Cash ratio
- 0.67x
- Interest coverage
- 7.89x
- EBITDA / interest
- 9.17x
- Working capital
- $11.0B
Cash & dividend
- FCF / debt
- 0.21x
- Cash flow / debt
- 0.24x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -81.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026